China Resources Double Crane (600062.SH) intends to have some of its drugs selected for the national centralized drug procurement.

Zhitong Finance APP reported that China Resources Double Crane (600062.SH) announced that on July 31, 2026, the company and several of its subsidiaries participated in the twelfth national centralized procurement bidding organized by the Joint Procurement Office. The company plans to have some products, including Amlodipine and Benazepril oral immediate-release formulations, selected for this centralized procurement.